The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Fractalkine‐induced activation of the phosphatidylinositol‐3 kinase pathway attentuates microglial activation in vivo and in vitro
Abstract
Several neurodegenerative disorders are associated with evidence of inflammation, one feature of which is increased activation of microglia, the most likely cellular source of inflammatory cytokines like interleukin‐1β. It is now recognized that interaction of microglia with other cells contributes to maintenance of microglia in a quiescent state and the complementary distribution of the chemokine, fractalkine (CX 3 CL1) on neurons and its receptor (CX 3 CR1) on microglia, suggests that this interaction may play a role in modulating microglial activation. Here we demonstrate that both soluble and membrane‐bound fractalkine attenuate lipopolysaccharide‐induced microglial activation in vitro. We also show that fractalkine expression is reduced in the brain of aged rats and this is accompanied by an age‐related increase in microglial activation. Treatment of aged rats with fractalkine attenuates the age‐related increase in microglial activation and the evidence indicates that fractalkine‐induced activation of the phosphatidylinositol‐3 kinase pathway is required to maintain microglia in a quiescent state both in vivo and in vitro.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The immunosuppressor proteins, including CX3CL1 and CD47 (to control microglial and macrophage function) and CFH (to control T-cell activation and block complement triggers), are already activated by neurodegeneration and block the overproduction of pro-inflammatory signals (such as inducible nitric oxide synthase, interleukin (IL)-1β, tumor necrosis factor-α (TNF-α), and IL-6) [61,62].”
From Risk mitigation of immunogenicity: a key to personalized retinal gene therapy (2021) · cites this paper as [61]
Citations
Cites
Alternative activation of macrophages
Gordon, S. (2003) · Nature Reviews Immunology · doi:10.1038/nri978 · Cited by 6,189
Long-Term Potentiation and Memory
Lynch, M. A. (2004) · Physiological Reviews · doi:10.1152/physrev.00014.2003 · Cited by 2,075
Self-citationA new class of membrane-bound chemokine with a CX3C motif
Bazan, J. F., Bacon, K. B., Hardiman, G., Wang, W., Soo, K., Rossi, D., Greaves, D. R., Zlotnik, A., & Schall, T. J. (1997) · Nature · doi:10.1038/385640a0 · Cited by 2,013
Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism
Block, M. L., & Hong, J.-S. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.06.004 · Cited by 1,557
Control of microglial neurotoxicity by the fractalkine receptor
Cardona, A. E., Pioro, E. P., Sasse, M. E., Kostenko, V., Cardona, S. M., Dijkstra, I. M., Huang, D., Kidd, G., Dombrowski, S., Dutta, R., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1715 · Cited by 1,531
Harrison, J. K., Jiang, Y., Chen, S., Xia, Y., Maciejewski, D., McNamara, R. K., Streit, W. J., Salafranca, M. N., Adhikari, S., Thompson, D. A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10896 · Cited by 1,176
Godbout, J. P., Chen, J., Abraham, J., Richwine, A. F., Berg, B. M., Kelley, K. W., & Johnson, R. W. (2005) · The FASEB Journal · doi:10.1096/fj.05-3776fje · Cited by 813
Microglial response to amyloid plaques in APPsw transgenic mice.
Frautschy, S. A., Yang, F., Irrizarry, M., Hyman, B. T., Saido, T. C., Hsiao, K., & Cole, G. M. (1998) · Europe PMC (PubMed Central) · Cited by 592
CD200 and membrane protein interactions in the control of myeloid cells
Barclay, A. N., Wright, G. J., Brooke, G. P., & Brown, M. H. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02223-8 · Cited by 422
Expression of CX 3 CR1 chemokine receptors on neurons and their role in neuronal survival
Meucci, O., Fatatis, A., Simen, A. A., & Miller, R. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.090017497 · Cited by 385
Cited by
Sorted by citations
Items 101–200 of 202
Fractalkine suppression during hepatic encephalopathy promotes neuroinflammation in mice
McMillin, M., Grant, S., Frampton, G., Andry, S., Brown, A., & DeMorrow, S. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0674-8 · Cited by 32
Microglia in Alzheimer’s Disease: An Unprecedented Opportunity as Prospective Drug Target
Kulkarni, B., Martins, N. A., & Kumar, D. (2022) · Molecular Neurobiology · doi:10.1007/s12035-021-02661-x · Cited by 38
The emerging role of brain neuroinflammatory responses in Alzheimer’s disease
AmeliMojarad, M., AmeliMojarad, M., & Cui, X. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1391517 · Cited by 34
Murai, N., Mitalipova, M., & Jaenisch, R. (2020) · European Journal of Neuroscience · doi:10.1111/ejn.14879 · Cited by 33
Chen, M., Luo, C., Peñalva, R. G., & Xu, H. (2013) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-10888 · Cited by 33
Role of MSK1 in the Induction of NF-κB by the Chemokine CX3CL1 in Microglial Cells
Galán-Ganga, M., García‐Yagüe, Á. J., & Lastres‐Becker, I. (2019) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-019-00664-w · Cited by 30
Aurelian, L., & Balan, I. S. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05220-4 · Cited by 31
Sanchez-Molina, P., Almolda, B., Giménez‐Llort, L., González, B., & Castellano, B. (2022) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.12.026 · Cited by 32
Hill, S. L., Shao, L., & Beasley, C. L. (2020) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2020.1755451 · Cited by 29
Thompson, H. J., Martha, S. R., Wang, J., & Becker, K. J. (2020) · Journal of Head Trauma Rehabilitation · doi:10.1097/htr.0000000000000606 · Cited by 28
Wang, D., Tian, T., Dong, Q., Xu, X., Yu, H., Wang, Y., & Chen, Z.-Y. (2013) · Hippocampus · doi:10.1002/hipo.22204 · Cited by 26
Fractalkine stimulates cell growth and increases its expression via NF ‐κ B pathway in RA ‐ FLS
Guo, X., Pan, Y., Xiao, C., Wu, Y., Cai, D., & Gu, J. (2012) · International Journal of Rheumatic Diseases · doi:10.1111/j.1756-185x.2012.01721.x · Cited by 26
Modulatory effects of mesenchymal stem cells on microglia in ischemic stroke
Hao, L., Yang, Y., Xu, X., Guo, X., & QunLing, Z. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2022.1073958 · Cited by 25
Microglia in retinal diseases: From pathogenesis towards therapeutic strategies
Xiao, R., Huang, X., Gao, S., Duan, J., Zhang, Y., & Zhang, M. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116550 · Cited by 28
Guo, L. C., Lu, X., Wang, Y., Bao, C., & Chen, S. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4862 · Cited by 24
Microglia in motor neuron disease: Signaling evidence from last 10 years
Wang, M., Lu, K., Wang, Y., Yang, B., Zhang, C., Lu, Y., & Kang, L. (2022) · Developmental Neurobiology · doi:10.1002/dneu.22905 · Cited by 23
How dependent is synaptic plasticity on microglial phenotype?
Jones, R. S., & Lynch, M. A. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.08.012 · Cited by 25
Self-citationSeneff, S., & Morley, W. A. (2014) · Surgical Neurology International · doi:10.4103/2152-7806.134731 · Cited by 25
The Role of Microglia in the Etiology and Evolution of Chronic Traumatic Encephalopathy
Makinde, H. M., Just, T. B., Cuda, C. M., Perlman, H., & Schwulst, S. J. (2017) · Shock · doi:10.1097/shk.0000000000000859 · Cited by 24
Aging Microglia: Relevance to Cognition and Neural Plasticity
Kohman, R. A. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-071-7_11 · Cited by 25
Infiltrating macrophages contribute to age-related neuroinflammation in C57/BL6 mice
Wolfe, H. E., Minogue, A. M., Rooney, S., & Lynch, M. A. (2018) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2018.05.003 · Cited by 24
Self-citationModulation of inflammatory responses by fractalkine signaling in microglia
Inoue, K., Morimoto, H., Ohgidani, M., & Ueki, T. (2021) · PLOS ONE · doi:10.1371/journal.pone.0252118 · Cited by 22
Microglial modulators reduce respiratory rhythm long-term facilitation in vitro
Camacho-Hernández, N. P., Lorea-Hernández, J. J., & Peña‐Ortega, F. (2018) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2018.07.012 · Cited by 22
Potential Immunotherapeutic Targets on Myeloid Cells for Neurovascular Repair After Ischemic Stroke
Zhu, Z., Li, Z., Li, Y., Huang, T., Chao, Y.-C., Pan, L., Zhu, H. F., Zhao, Y., Yu, W., & Li, P. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00758 · Cited by 22
Loss of NF-κB p50 function synergistically augments microglial priming in the middle-aged brain
Taetzsch, T., Benusa, S. D., Levesque, S., Mumaw, C. L., & Block, M. L. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1446-z · Cited by 21
Involvement of CX3CL1/CX3CR1 Signaling in Spinal Long Term Potentiation
Bian, C., Zhao, Z., Zhang, Y., & Lü, N. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118842 · Cited by 21
Hussien, Y. A., Mansour, D. F., Nada, S. A., El‐Rahman, S. S. A., Abdelsalam, R. M., Attia, A. S., & El-Tanbouly, D. M. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120378 · Cited by 20
Risk mitigation of immunogenicity: a key to personalized retinal gene therapy
Varin, J., Morival, C., Maillard, N., Adjali, O., & Cronin, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222312818 · Cited by 19
Painful Neuron-Microglia Interactions in the Trigeminal Sensory System
Davies, A. J., Kim, Y. H., & Oh, S. B. (2010) · The Open Pain Journal · doi:10.2174/1876386301003010014 · Cited by 19
Baidoe‐Ansah, D., Sakib, M. S., Jia, S., Mirzapourdelavar, H., Strackeljan, L., Fischer, A., Aleshin, S. E., Kaushik, R., & Dityatev, A. E. (2022) · Cells · doi:10.3390/cells11132033 · Cited by 16
Concentration and proteolysis of CX3CL1 may regulate the microglial response to CX3CL1
Finneran, D. J., Li, Q., Subbarayan, M. S., Joly‐Amado, A., Kamath, S. G., Dengler, D. G., Gordon, M. N., Jackson, M. R., Morgan, D., Bickford, P. C., et al. (2022) · Glia · doi:10.1002/glia.24269 · Cited by 18
Age-dependent changes on fractalkine forms and their contribution to neurodegenerative diseases
Eugenín, J. L., Bernhardi, L. E.-V., & Rommy von Bernhardi, M. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1249320 · Cited by 19
Drechsler, S., Lynch, M. A., Novella, S., Navarro, H. G., Hecimovic, S. K., Barini, E., Tucci, V., Castro, R. E., Vandenbroucke, R. E., Osuchowski, M. F., et al. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.07.005 · Cited by 20
Self-citationArcuri, C., Mecca, C., Giambanco, I., & Donato, R. (2019) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2019.04.005 · Cited by 19
Fractalkine Attenuates Microglial Cell Activation Induced by Prenatal Stress
Ślusarczyk, J., Trojan, E., Głombik, K., Chamera, K., Roman, A., Budziszewska, B., & Basta‐Kaim, A. (2016) · Neural Plasticity · doi:10.1155/2016/7258201 · Cited by 17
RetractedProinflammatory cytokines and their receptors as druggable targets to alleviate pathological pain
Kalpachidou, T., Riehl, L., Schöpf, C. L., Uçar, B., & Kress, M. (2022) · Pain · doi:10.1097/j.pain.0000000000002737 · Cited by 17
Hao, F., Zhang, N., Zhang, D., Bai, H., Piao, H. Z., Yuan, B., Zhu, H.-Y., Yu, H., Xiao, C.-S., & Li, A.-P. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1010-7 · Cited by 17
Understanding Microglia–Neuron Cross Talk: Relevance of the Microglia–Neuron Cocultures
Correa, F., Hernangómez, M., & Guaza, C. (2013) · Methods in molecular biology · doi:10.1007/978-1-62703-520-0_20 · Cited by 17
Sex and Region-Specific Differences in Microglial Morphology and Function Across Development
Bishnoi, I. R., & Bordt, E. A. (2025) · Neuroglia · doi:10.3390/neuroglia6010002 · Cited by 19
Deciphering the Enigma of Neuron-Glial Interactions in Neurological Disorders
Ahmad, S. R., Zeyaullah, M., AlShahrani, A. M., Dawria, A., Ali, H., Mohieldin, A., Altijani, A. A. G., Razi, U., Mehdi, M., Akram, S., et al. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2904142 · Cited by 15
Li, Z., Cao, X., Ma, H., Cui, Y., Li, X., Wang, N., & Zhou, Y. (2018) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly051 · Cited by 15
Blaylock, R. L., & Maroon, J. C. (2012) · Royal Society of Chemistry eBooks · doi:10.1039/9781849734745-00045 · Cited by 16
Reguilón, M. D., Perez, C. F., Manzanedo, C., Miñarro, J., & Rodríguez‐Arias, M. (2021) · Neurobiology of Stress · doi:10.1016/j.ynstr.2021.100413 · Cited by 15
CX 3 CR 1 RNA i inhibits hypoxia‐induced microglia activation via p38 MAPK / PKC pathway
Liu, Y., Zhao, T., Yang, Z., & Li, Q. (2014) · International Journal of Experimental Pathology · doi:10.1111/iep.12065 · Cited by 15
Microglial Dysfunction in Autism Spectrum Disorder
Meng, J., Zhang, L., & Zhang, Y. (2024) · The Neuroscientist · doi:10.1177/10738584241252576 · Cited by 15
CX3C chemokine: Hallmarks of fibrosis and ageing
Chen, X., Yang, Y., Sun, S., Liu, Q., Yang, Y., & Jiang, L. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107348 · Cited by 13
Chemokine CX3CL1 (Fractalkine) Signaling and Diabetic Encephalopathy
Wątroba, M., Grabowska, A. D., & Szukiewicz, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25147527 · Cited by 13
Flierl, U., Fraccarollo, D., Lausenmeyer, E., Rosenstock, T., Schulz, C., Maßberg, S., Bauersachs, J. K., & Schäfer, A. (2012) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.112.250720 · Cited by 13
Endocannabinoid Signaling for GABAergic-Microglia (Mis)Communication in the Brain Aging
Carrera, J., Tomberlin, J., Kurtz, J., Karakaya, E., Bostancıklıoğlu, M., & Albayram, Ö. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.606808 · Cited by 12
Shedding light on the role of CX3CR1 in the pathogenesis of schizophrenia
Chamera, K., Szuster-Głuszczak, M., & Basta‐Kaim, A. (2021) · Pharmacological Reports · doi:10.1007/s43440-021-00269-5 · Cited by 12
Zhan, L., Qiu, M., Zheng, J., Lai, M., Lin, K., Dai, J., Sun, W., & Xu, E. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01830-4 · Cited by 11
Research and progress on biomarkers of neuromyelitis optica spectrum disorders
Wang, J., Liu, J., Li, R., & Wang, C. (2020) · Journal of Receptors and Signal Transduction · doi:10.1080/10799893.2020.1830109 · Cited by 10
Du, R., Zhang, J., Lukas, R. V., Tripathi, S., Ahrendsen, J. T., Curran, M. A., Dmello, C., Zhang, P., Stupp, R., Rao, G., et al. (2024) · Neuro-Oncology · doi:10.1093/neuonc/noae193 · Cited by 11
Vera, D. M., Martín-Chaves, L., Sánchez‐Marín, L., Díaz-Ottaviano, M., Gavito, A., Popova, O., Sanchez‐Quintero, M. J., Rodríguez‐Capitán, J., de Fonseca, F. R., Jiménez-Navarro, M. F., et al. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110503 · Cited by 8
The age- and amyloid-β-related increases in Nogo B contribute to microglial activation
Murphy, K. J., Miller, A., Thelma, R., Cowley, F., Cox, F., & Lynch, M. A. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.11.009 · Cited by 9
Self-citationMicroglia: The Bodyguard and the Hunter of the Adult Neurogenic Niche
Valero, J., Eiriz, M. F., Santos, T., Neiva, I., Ferreira, R., & Malva, J. O. (2012) · Humana Press eBooks · doi:10.1007/978-1-61779-940-2_14 · Cited by 9
Imipramine and Venlafaxine Differentially Affect Primary Glial Cultures of Prenatally Stressed Rats
Obuchowicz, E., Bielecka, A., Zielinski, M. W., Machnik, G., Gołyszny, M. J., & Ludyga, T. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01687 · Cited by 8
Stojić-Vukanić, Z., Pilipović, I., Djikić, J., Vujnović, I., Nacka-Aleksić, M., Bufan, B., Arsenović-Ranin, N., Kosec, D. J., & Leposavić, G. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2017.11.002 · Cited by 9
Kim, K.-J., Hwang, J., Lee, K., Kim, J., Han, Y., & Namgung, U. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04054-2 · Cited by 7
Chronic neuroinflammation impairs waste clearance in the rat brain
Suresh, S., Larson, J., & Jenrow, K. A. (2022) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2022.1013808 · Cited by 7
Ma, C. T., Lee, S. B., Cho, I. H., Yu, J. S., Huang, T., Lee, T. M., Lý, T. L., Kwon, S. W., Park, J. H., & Yang, H. O. (2023) · ACS Omega · doi:10.1021/acsomega.3c05783 · Cited by 7
Manickam, V., Maity, S., Murali, S. V., Gawande, D. Y., Stothert, A. R., Batalkina, L., Cardona, A. E., & Kaur, T. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1486740 · Cited by 7
Zhong, W., Kokhaei, P., Mulder, T. A., Ghaderi, A., Moshfegh, A., Lundin, J., Palma, M., Schultz, J., Olin, T., Österborg, A., et al. (2024) · Cancers · doi:10.3390/cancers16223821 · Cited by 7
Neuronal DJ-1 regulates microglial activation in Parkinson’s disease
Zhao, A., Ding, Y., Zhong, M., Niu, M., Wang, L., Jiao, Y., Liu, J., & Li, Y. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01047 · Cited by 6
Peng, Q., Shi, L., Kong, Y., Yan, Y. C., Zhan, J., Wen, Y., Liu, W., De-xian, Y., Zhou, Z., & Yan, H. (2020) · Brain Research · doi:10.1016/j.brainres.2020.146801 · Cited by 6
Analysis of the Impact of CD200 on Neurodegenerative Diseases
Miller, A., Brian, F., Downer, E. J., Lyons, A., Henrich‐Noack, P., Nolan, Y. M., & Marina, A. (2011) · InTech eBooks · doi:10.5772/32003 · Cited by 5
Self-citationAnalysis of Givinostat/ITF2357 Treatment in a Rat Model of Neonatal Hypoxic-Ischemic Brain Damage
Pawelec, P., Sypecka, J., Zalewska, T., & Ziemka‐Nałęcz, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158287 · Cited by 6
Gawande, D. Y., Murali, S. V., Thakur, S. S., Rahmatulloev, S., Nicolaisen, E., Batalkina, L., Cardona, A. E., & Kaur, T. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03524-1 · Cited by 5
The role of glial cells in amyotrophic lateral sclerosis
Pandya, V. A., & Patani, R. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.04.005 · Cited by 5
Bruszt, N., Bali, Z. K., Nagy, L. V., Bodó, K., Engelmann, P., & Hernádi, I. (2025) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyaf014 · Cited by 4
Are Inflammatory Profiles the Key to Personalized Alzheimer's treatment?
Brothers, H. M., & Wilcock, D. M. (2013) · Neurodegenerative Disease Management · doi:10.2217/nmt.13.40 · Cited by 3
Jones, C. L., Parkitny, L., Strath, L. J., Wagener, B. M., Barker, A. B., & Younger, J. (2023) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2023.100707 · Cited by 5
Ortiz, A. A., Murtishaw, A. S., Beckholt, M., Salazar, A., Osse, A. M. L., & Kinney, J. W. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01618-6 · Cited by 3
Olayinka, O. A., O’Neill, N. K., Empawi, J. A., Bock, P., Hu, J., Rickner, H., Wong, M., Stein, T. D., Wolozin, B. L., Farrer, L. A., et al. (2025) · Neurobiology of Disease · doi:10.1016/j.nbd.2025.107128 · Cited by 5
The Endocannabinoid System in Local and Systemic Inflammation
Kelly, M. E. M., Lehmann, C., & Zhou, J. (2017) · Colloquium Series on Integrated Systems Physiology From Molecule to Function · doi:10.4199/c00151ed1v01y201702isp074 · Cited by 4
Epigenetic mechanism of carbohydrate sulfotransferase 3 ( CHST3 ) downregulation in the aging brainPreprint
Baidoe‐Ansah, D., Sakib, M. S., Jia, S., Fischer, A., Kaushik, R., & Dityatev, A. E. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/741355 · Cited by 3
Medina, A., Chen, Y.-C., Zhang, J., Ogden, S. C., Cotsmire, S., Vishwasrao, H. D., Ferrer, M., & Lee, E. M. (2025) · Antiviral Research · doi:10.1016/j.antiviral.2025.106248 · Cited by 2
Uncovering the Path to Neurodegeneration from Playingfield to Battlefield
Baas, F., & Ramagli, V. (2014) · InTech eBooks · doi:10.5772/57186 · Cited by 1
Impaired Signaling of NF-κB and NRF2 in CX3CR1-Deficient Microglia: Implications in TauopathiesPreprint
Castro‐Sánchez, S., García‐Yagüe, Á. J., Kügler, S., & Lastres‐Becker, I. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/346304 · Cited by 2
Association between influenza A virus and SARS-CoV-2 infections and mood disorders
Xiang, Y., Wang, W., Zhu, J., Chen, Z., & Huang, W. (2026) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2026.101182 · Cited by 1
Zheng, X., Zhang, X., Zhang, Y., Chen, C., & Ji, E. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1392437 · Cited by 1
Microglial Biology and Physiology
Butovsky, O., Madore, C., & Weiner, H. L. (2016) · Springer eBooks · doi:10.1007/978-3-319-44022-4_13 · Cited by 1
Contribution of Neuroinflammation in the Pathogenesis of Alzheimer’s Disease
Farooqui, A. A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809937-7.00006-9 · Cited by 1
Aspirin modulates the inflammatory response in a thrombus‑stimulated LMVEC model
Wang, L., Ying, R., Jiang, H., Jin, Q., Kuang, J., Zhang, Z., Shi, Y., Cai, D., & Yang, R. (2018) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2018.3561 · Cited by 1
Pabon, M. M. (2011) · Digital Commons - University of South Florida (University of South Florida) · Cited by 1
Microglia: A Double-Sided Sword in Stroke
Shi, H., Xu, M., Shi, Y., Gao, Y., Chen, J., & Hu, X. (2016) · Springer series in translational stroke research · doi:10.1007/978-3-319-32337-4_7
Defining microglial phenotypic diversity and the impact of ageing
Grabert, K. (2015) · ERA
Different Roles of Microglia/Macrophage in Ischemic Stroke and Alzheimer's Disease
Li, S., Cao, R., Guo, L., & Shi, J. (2017) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000364
Fractalkine signaling in psychiatric disorder : observations in the postmortem brain
Hill, S. L. (2019) · cIRcle (University of British Columbia) · doi:10.14288/1.0384590
Çalışkan, G., French, T., Heimesaat, M. M., Dunay, I. R., & Stork, O. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.30.454300
Targeting pathological changes in the gut protects the CNS from neuropathology.
Charpentier, B. (2022) · ThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · doi:10.18297/etd/3966
Abboussi, O., Khan, Z. A., Ibork, H., Zulu, S. S., Daniels, W. M. U., Taghzouti, K., & Hales, T. G. (2023) · Research Square · doi:10.21203/rs.3.rs-2483808/v1
Genotype–phenotype interaction in Alzheimer's disease immune activation
Knudtzon, S. L., Kirsebom, B., Pålhaugen, L., Bettella, F., Gísladóttir, B., Bahrami, S., Athanasiu, L., Rongve, A., Nakling, A. E., Almdahl, I. S., et al. (2026) · Alzheimer s & Dementia · doi:10.1002/alz.70978
CX3CL1/CX3CR1 axis dysregulation contributes to epileptogenic mechanisms in focal cortical dysplasia
Lei, L., Yang, S., Li, Y., Tian, J., Fang, Y., Huang, T., Chen, S., & Zhou, L. (2026) · Acta Neuropathologica Communications · doi:10.1186/s40478-026-02274-2
Sobhani, A., Sadr, N. K. S., Shahpasand, K., Mirnajafi‐Zadeh, J., & Behmanesh, M. (2026) · Life Sciences · doi:10.1016/j.lfs.2026.124342
Jie, Y., Lai, Z., Zhou, W., Li, Y.-C., Zhong, B.-L., Zeng, X.-X., & Jiang, Q. (2026) · World Journal of Psychiatry · doi:10.5498/wjp.v16.i4.115567
Chataigner, M. (2021) · theses.fr (ABES) · doi:10.70675/a4317690zc4c8z4ba6za738zd457c6bb9b74
Hemonnot-Girard, A.-L. (2021) · theses.fr (ABES) · doi:10.70675/9c8a4775zd774z494ez9bbazf7566faefa8f
Microglia detection and phagocytosis of dying neurons is regulated by CX3CR1Preprint
Barasa, M. N., Pietramale, A. N., & Hill, R. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.02.716180
Metadata
- Authors
- Lyons, A., Lynch, A. M., Downer, E. J., Hanley, R., O’Sullivan, J. B., Smith, A., & Lynch, M. A.
- Affiliations
- Trinity College Dublin (IE)
- Corresponding author
- Lynch, Marina A.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2009-08-10
- Volume
- 110
- Issue
- 5
- Pages
- 1547-1556
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2036586619
- Cited by
- 202
- References
- 46
- Citations by year
- 2026: 8 · 2025: 8 · 2024: 16 · 2023: 9 · 2022: 15 · 2021: 12 · 2020: 12 · 2019: 16 · 2018: 11 · 2017: 13 · 2016: 12 · 2015: 5 · 2014: 10 · 2013: 16 · 2012: 11
- FWCI
- 8.31
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Neurochemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Science Foundation Ireland
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Keywords
- fractalkine, CX3CR1, microglial activation, phosphatidylinositol 3-kinase pathway, neuroinflammation, lipopolysaccharide, aging, neurodegenerative diseases, IL-1β, microglia-neuron interaction
- MeSH terms
- Age Factors, Aging, Animals, Animals, Newborn, Cells, Cultured, Enzyme Activation, Lipopolysaccharides, Male, Membrane Proteins, Solubility, Signal Transduction, Rats, Wistar, Microglia, Phosphatidylinositol 3-Kinases, Rats, Chemokine CX3CL1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review